National drug abuse treatment clinical trials network expands

October 30, 2000

NIDA Network now includes 11 research centers and nearly 70 treatment programs

The National Drug Abuse Treatment Clinical Trials Network launched a year ago by the National Institute on Drug Abuse (NIDA) with grants to six research facilities has been expanded to include an additional five regional research centers and a total of almost 70 community based treatment programs.

"Our over-arching goal is to improve the quality of drug abuse treatment throughout the Nation, using science as the vehicle. By expanding the Clinical Trials Network we will shorten the time it takes to bring the findings of laboratory research about addiction to useful implementation in real-life community treatment settings," explained Dr. Alan I. Leshner, NIDA director.

The five newly funded centers each will receive a total of $11 million over five years. The total funding for all 11 components of the Clinical Trials Network is $121 million over five years.

NIDA announced the Clinical Trials Network (CTN) in January 1999 based on a recommendation made in the 1998 Institute of Medicine Report, "Bridging the Gap Between Research and Practice." The first grants were awarded in September 1999. When complete, the network will consist of 20 to 30 regional centers. Each center will be linked with 10 to 15 community treatment programs that represent a variety of treatment settings and patient populations in that region of the country.

Funding for the following five centers was announced today: Each center's treatment programs respond to diverse patient populations. For example:
* The Southeastern node's programs focus on women, African Americans, and adolescents.
* The Florida Node covers the entire state and includes programs for adolescent and family treatment, treatment for HIV/AIDS, and mobile counseling.
* The Great Lakes Regional Node includes a therapeutic community for the indigent, many of whom also have mental disorders, as well as urban and suburban methadone maintenance programs.
* The Ohio Valley Node, which encompasses Kentucky, Ohio, West Virginia, and Indiana, serves patients from rural, Appalachian areas and urban, industrial areas.
* The Rocky Mountain Node, in addition to serving a racially and ethnically diverse population, also cares for injecting drug users with a high risk of HIV.
-end-
Funding for the following six centers was announced previously: The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish by calling NIDA Infofax at 1-888-NIH-NIDA (644-6432) or 1-888-TTY-NIDA (889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov.

NIH/National Institute on Drug Abuse

Related Drug Abuse Articles from Brightsurf:

Job skills training leads to long-term reduction in drug abuse
Job skills training for low-income youth does more than just help them get better jobs - it makes them significantly less likely than others to use some illicit drugs, even 16 years later.

Drug reduces the risk of child sexual abuse
A drug that lowers levels of the male hormone testosterone in the body reduces the risk of men with pedophilic disorder sexually abusing children, a study from Karolinska Institutet published today in the journal JAMA Psychiatry shows.

Recovery from sperm suppression due to performance-enhancing drug abuse is slow
Decreased sperm and testosterone production caused by abuse of performing-enhancing hormones may be fully reversible once men stop taking the drugs, but full recovery can take at least nine to 18 months, according to research to be presented Sunday, March 24 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

URI drug study produces 'promising therapy' for alcohol abuse
A University of Rhode Island College of Pharmacy professor is working to change that, and a new clinical trial is right around the corner.

Parental attention can reduce risk of drug abuse in adolescence
Survey of more than 6,000 teenagers performed by Brazilian researchers reinforces protective function of rule-keeping, which relies on open dialogue about the importance of rules as much as on children's monitoring.

ADHD medication tied to lower risk for alcohol, drug abuse in teens and adults
The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study published in the American Journal of Psychiatry and led by Indiana University.

Stopping drug abuse can reverse related heart damage
Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical treatment, potentially preventing future drug-related cases of heart failure or other worse outcomes, according to a study published today in JACC: Heart Failure.

Opioid abuse drops when doctors check patients' drug history
There's a simple way to reduce the opioid epidemic gripping the country, according to new Cornell University research: Make doctors check their patients' previous prescriptions.

Alcohol abuse drug can be repurposed to treat a blinding disorder
Disulfiram prevents scars forming in a mouse model of scarring conjunctivitis.

Prescription drug abuse in Europe is a bigger problem than previously thought
International collaborations across the EU are needed to monitor prescription drug abuse, identify its scope and develop targeted interventions, according to the first comparative study of prescription drug abuse in the European Union.

Read More: Drug Abuse News and Drug Abuse Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.